Expression of interleukin-37 (IL37) and the genetic variations of IL37 in relation to chronic periodontitis by Zhang, Shaoping
  
EXPRESSION OF INTERLEUKIN-37 (IL37) AND THE 
 GENETIC VARIATIONS OF IL37 IN RELATION TO CHRONIC PERIODONTITIS 
 
 
 
 
 
Shaoping Zhang 
 
 
 
 
 
A thesis submitted to the faculty of the University of North Carolina at Chapel Hill in partial 
fulfillment of the requirements for the degree of Master of Science in the Department of 
Periodontology in the School of Dentistry. 
 
 
 
 
 
Chapel Hill 
2014 
 
 
 
 
                                                                                                                Approved by: 
                                                                                                                Steven Offenbacher 
                                                                                                                James D. Beck 
                                                                                                                Barros P. Silvana
 ii 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
© 2014 
Shaoping Zhang 
ALL RIGHTS RESERVED   
 iii 
 
 
ABSTRACT 
 
Shaoping Zhang: Expression of Interleukin-37 (IL37) and the Genetic Variations of IL37 in 
Relation to Chronic Periodontitis 
 (Under the direction of Steven Offenbacher) 
Objectives: To study the transcription of IL37 in gingival biopsies and the 
association between transcription of IL1B, IL6 and IL37 and genotypes at the rs3811046 and 
rs3811047 IL37 loci. Materials and Methods : Gingival biopsies were collected from 
chronic periodontitis patients and control subjects. Pyrosequencing was applied for 
genotyping. Real-time PCR was used to examine the transcription of genes from biopsies and 
cell culture models. Results: Transcription of IL6 was significantly higher in periodontitis 
samples.  Transcription of IL37 was induced in oral epithelial and THP.1 cells by LPS. The 
presence of a minor allele at both loci in IL37 was significantly related to a reduced IL6 
transcription in Caucasians, while the major allele was associated with a higher transcription 
of IL6 in African Americans. Conclusion: Gingival epithelium and monocytic cells are the 
major source for IL-37. The genetic variants of IL37 related to the altered transcription of IL6 
are race specific. 
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CHAPTER 1: REVIEW OF INTERLEUKIN-37 (IL37), A NOVEL ANTI-
INFLAMMATORY IL-1FAMILY MEMBER 
 
Introduction 
 
Periodontal disease has been described as an abnormal inflammatory response to the 
pathogenic bacteria present in the bioflim. The uncontrolled inflammatory and immune 
responses initiated by the bacteria are  the major etiology of periodontal destruction1, 2 
Activation of the innate immune system in periodontal d isease leads to the rapid secretion of 
various chemokines and cytokines, such as interleukin-1β, (IL-1β), IL-6, IL-8, TNF-α, etc., 
most of which propagate inflammation and may potentially cause destruction in 
periodontium. For example, an elevated level of gingival crevicular fluid (GCF) IL-1β has 
previously been established as a robust biomarker for a hyper- inflammatory phenotype and 
for mediating severe inflammation, bone loss and periodontal disease progression3. Although 
feedback mechanisms might be present to dampen inflammation, only several secreted 
molecules have been described to possess anti- inflammatory activities, such as resolvins, IL-
10 and transforming growth factor β (TGF-β) among more than 50 known cytok ines4. 
Pathways to downregulate the extent and severity of inflammation in hosts may provide 
insight for the therapeutic potential to reduce the destruction caused by periodontal disease.  
The course of inflammation is not only determined by the proinflammatory molecules 
but critically modified by resolution mechanisms that counteract the inflammation induced 
by pathogens. The disequilibrium of the pro- and anti-  inflammatory pathways in 
periodontium results in the disease progression as evidenced by destruction of tooth 
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supporting apparatus. During the prolonged battle with pathogenic microorganisms that are 
present in the biofilm, the host may have developed dampening mechanisms that inhibit the 
uncontrolled inflammation. It has been suggested that periodontal inflammation resulting in 
the destruction of tooth-supporting tissue is partially due to the lack of adequate resolution 
activities 5.    
Anti-inflammatory mechanisms involved in periodontal disease 
 
A class of small lipid molecules, which are termed resolvins, has been elucidated to 
possess the capacity to promote the resolution of inflammation5, 6. Resolvins are derived from 
eicosapentaenoic acid and the production of resolvins shares the similar pathway of the 
metabolism of arachidonic acid. The activities of resolvins include reduction of neutrophile 
trafficking, control of cytokine production and reactive oxygen species, and mitigation of the 
magnitude of the inflammatory responses. Van Dyke et al. proved that the application of 
resolving E1 in a rabbit model at the same time when the experimental periodontitis was 
induced inhibited the onset and progression of periodontal destruction5. Interestingly, 
resolving E1 also demonstrated therapeutic efficacy because the application of this molecule 
in the established periodontitis in the rabbit model complete ly eliminated inflammation and 
the pocket depth was returned to pre-ligature condition5.  
Another molecule that possesses the inflammation resolving activity is transforming 
growth factor-β (TGF-β). TGF-β antagonizes IL-1 activity, and it also promotes both the 
synthesis of extracellular matrix proteins and proteinase inhibitors, such as tissue  inhibitors 
of metalloproteinases (TIMPs) and plasminogen activator inhibitor-1 (PAI-I), which inhibit 
the synthesis of matrix metalloproteinase proteins (MMPs) 7.  Matsuda et al. reported that 
addition of TGF-β to the cell medium directly stimulated collagen synthesis in rat periodontal 
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ligament fibroblastic cells 8. In addition, the stimulation with TGF-β progressively decreased 
the expression of procollagenase and increased both the mRNA and protein levels of TIMP 9. 
TGF-β has also been identified to play a pivotal role in the mediation of the 
immunosuppressive activity of regulatory T (Treg) cells 10,11. In gingival crevicular fluid, the 
level of TGF-β was elevated in both chronic and aggressive forms of periodontitis and such 
an increase was interpreted as a mechanism to act against detrimental immune and 
inflammatory responses and, therefore, may prevent further loss of periodontium 10.  
Epigenetic modifications have recently been suggested as one of the most important 
regulatory mechanism for cytokine production in inflammatory disease including 
periodontitis 12, 13. DNA methylation and histone modifications, which are two major types of 
epigenetic regulation, modulate host response at the chromatin level to environmental 
stressors, including smoking, nutrient deficiency, bacterial infection, inflammation, etc 13. It 
is well known that stimuli as mentioned above can regulate cytokine gene expression through 
various signaling pathways. However, the enrichment of transcriptional factors in the nuclei 
induced by signal transduction may not account for the only driving force for gene 
expression. The state of chromatin confirmation, to which mammalian genes are packed, 
determines the transcriptional readiness of genes when the orchestration of signal 
transduction is not impaired and transcriptional factors are available14, 15. Therefore 
epigenetic regulation also plays a fundamental role in the control of gene expression.  DNA 
methylation, which almost always occurs to the cytokine nucleotide in the cytokine-guanine 
(CG) dinucleotides, is a more stable epigenetic mark and less likely to be reversed as 
compared to post-translational histone modifications 16.  
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We have proposed that the persistence challenge from the pathogenic microflora in 
the biofilm may modify the methylation level of the promoter regions of certain host 
inflammatory genes that are involved in the pathogenesis of chronic periodontitis. Employing 
clinical gingival biopsies, we have discovered a hypermethylation pattern within the 
promoter region of prostaglandin-endoperoxide synthase-2 (PTGS2 or COX2) and tumor 
necrosis factor α (TNFA) 17, 18. Using the same biological samples, we also found that the 
transcriptional level of both PTGS2 and TNFA genes was dampened and failed to elevate in 
comparison to the control samples that exhibited periodontal health 17. Such a 
hypermethylation pattern in the promoter region and an inhibited transcriptional profile also 
confirm the generally accepted paradigm that the degree of promoter methylation is inversely 
related to the transcriptional levels 19. Since TNF-α and PGE2, in which PTGS2 is a key 
regulatory gate for its production, are among the most critical pro- inflammatory cytokines in 
periodontal disease, the dysfunction of the regulatory mechanism for those molecules leads 
to disease progression. The increased methylation level change in the promoter regions of 
those genes may reflect a metastable mechanism that can create a new “set-point” of the 
inflammatory homeostasis in the disease state 18. Chronic periodontitis is a slow-progressing 
inflammatory/infectious disease featured by episodic periodontium destruction with long 
intervals of quiescence. In the chronic battle with the periodontal pathogens the host may 
develop a dampening compensatory mechanism through DNA methylation that helps to 
control the pronounced inflammatory response and therefore serves to prevent the 
unrestricted further tissue destruction.  
Genetic variation of genes involved in inflammatory response and periodontal disease  
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Periodontal disease, similar to most other complex inflammatory diseases, is a 
polygenic disorder involving gene to gene interaction. The susceptibility to periodontal 
disease, which is an inflammatory disease exhibiting a complex genetic trait, has been 
explored through association studies aiming to target genetic markers and candidate disease-
modifying genes by identification of single nucleotide polymorphisms (SNPs). Many 
previous studies have discovered important SNPs encoding molecules of the host defense 
system in chronic periodontitis 20, 21. Kornman et al first described a composite IL1 
polymorphism including -889bp (C to T transition) in IL1A and +3953bp (C to T transition) 
in IL1B that was significantly related to the severity of periodontitis in non-smoking 
Caucasians 22. Additionally, monocytes from individuals with homozygous IL1B +3953T 
allele were shown to produce 4-fold more IL-1β, and monocytes with heterozygous IL1B 
+3935T allele exhibited two-fold more IL-1β than cells without this SNP at the +3953 locus 
22, 23. Several later studies relating this composite IL1 polymorphism to either susceptibility to 
or severity of periodontal disease showed diverse outcomes. Papapanou et al in a cross-
sectional study found that although this IL1 genotype failed to distinguish control subjects 
from patients with periodontitis, it was related to the severity of periodontal disease 24. 
Walker and colleagues reported from a cross-sectional study that IL1 composite 
polymorphism is not associated with the susceptibility to localized aggressive periodontitis in 
an African American population 25. Armitage et al demonstrated that this composite was 
almost non-existent in a Chinese population and didn’t show any association with the onset 
of periodontal disease 26. McGuire and Nunn in a longitudinal study discovered that this 
composite polymorphism was related to the tooth loss 27. From those studies investigating the 
association between this IL1 composite polymorphism and periodontal disease it can be 
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concluded that IL1 genotype might be regarded as a severity factor in certain racial groups, 
especially non-smoking Caucasians population48. 
Other studies examined the association of polymorphisms of several other 
inflammatory genes with periodontal disease. A recent meta-analysis showed that the T 
variant at -819bp locus of IL10 seemed to be a risk factor among Caucasians for chronic 
periodontitis 28. Similarly, the A allele at -592bp locus of the same gene was also associated 
with an increased risk for chronic periodontitis in Caucasian population. Another recent 
meta-analysis concluded that -308bp A/G variations in the promoter region of TNFA is 
significantly related to the susceptibility to periodontitis in Brazilian, Asian and Turkish 
population 29. The same meta-analysis also found that the G/C polymorphism at -174bp IL6 
may increase the susceptibility to periodontitis in Brazilians, while the G/C variation at -
572bp locus of the same gene is more prevalent in European decedents with chronic 
periodontitis29. It is evident that the identified association of certain SNPs present in genes 
that are critically involved in immune responses in periodontal disease is usually population-
based and usually cannot be generalized across different racial groups.  
In addition to cytokine genes, polymorphisms of other genes linking cellular and 
humoral immune responses to bacterial infection in periodontium have also been investigated 
extensively. Fc receptors for immunoglobulin G (IgG) or FcγRs play a pivotal role in 
phagocytosis of macrophages, neutrophil activation, and antibody-dependent cell-mediated 
cytotoxicity of natural killer cells. The phagocytic activity of macrophages is triggered by 
opsonization, a process that the FcγR on the macrophage surface binds Fc portion of 
antibodies that coat the invading bacteria. The presence of polymorphisms in the FcγR gene 
structure may induce functional alterations that affect the susceptibility of the host to various 
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inflammatory diseases such as rheumatoid arthritis, systemic lupus erythematosus and 
periodontitis 30. So far several studies have targeted the association between various 
polymorphisms of different FcγR genes and periodontal disease. Yamatomo et al reported 
that the polymorphism in the FcγRIIa gene resulting in a homozygous H/H at the 131 residue 
was associated with chronic periodontitis in a Caucasian population 31. However, Sugita and 
colleagues found that a G to T transition at nucleotide 559 within FcγRIIIa that results in an 
amino acid substitution at 158 from valine to phenylalanine was significantly related to the 
recurrence of chronic periodontitis in a Japanese population32 . A study by Yasuda et al 
demonstrated that rather than polymorphism that resulting in the H allele in FcγRIIa, the A 
allele at the nucleotide 646 -184 in the intron 4 of FcγRIIb gene was over represented in 
chronic periodontitis patients as compared to healthy control in a Japanese population33. 
Similar to studies of IL1 composite polymorphism, the association between a specific allele 
or genotype in the FcγR  genes and periodontal disease is affected by the racial groups.  
Structure, expression profile, activity and genetic variation of Interleukin-37 (IL37)  
We have recently completed a genome-wide association study (GWAS) of 4910 
Caucasians with known levels of GCF IL-1β to identify candidate genes whose changes due 
to polymorphism are associated with elevated secretion of GCF IL-1β. We have identified  
two novel quantitative trait loci with missense mutations within the coding region of IL37 
that are both inversely and significantly associated with high GCF-IL-1β levels. IL37 was 
previously designated as IL-1 family member 7 (IL1F7) 34. IL37 is mapped to the cluster of 
genes on human chromosome 2, which contains other IL-1 family members except IL18 and 
IL33. IL37 May be exclusively expressed in human, since the mouse homolog hasn’t been 
identified yet 4. Sequencing analyses have shown that IL1F7 gene structure contains 6 exons 
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and five splicing variants present (IL1F7a-e). IL1F7b has been found to be the largest and 
include five of those six exons. The protein structure of IL37 comprises a 12 β-barrel strand 
and shares the common pattern of other IL-1 family particularly that of IL-18 4, 35.  Although 
none of the variants of IL-37 contains a typical signal peptide, both b-isoform and c- isoform 
encode a putative caspase-1 cleavage site. Many cell types or tissues have been reported to 
express IL-37 35. The constitutive IL37 mRNA has been found in the testis, thymus, uterus 
and colon35. Upon induction, peripheral blood mononuclear cells (PBMCs), dendritic cells 
and colon epithelial cells can express IL-3736, 37. It has been reported that microbial products 
such as lipopolysaccharide (LPS) that bind to toll- like receptors (TLRs) constitute the strong 
stimulation for IL-37 expression 36.  In addition, this molecule can be also detected in 
monocytes, plasma cells and breast carcinoma cells at the protein level 35.  Similar to IL18, 
the control of IL37 expression is mainly at the post-transcriptional level by an instability 
element encoded in exon 5 in its coding region.  Although it is structurally similar to other 
IL-1 family members, IL-37 has recently been reported to possess a unique and potent anti-
inflammatory activity, which is in sharp contrast to the pro- inflammatory activity of IL-1β 
and IL-18 36. Because mice don’t have known structural homolog of IL37, transgenic mice 
carrying human IL37 offers an excellent tool for the studying the role of IL37 in 
inflammation38. McNamee and colleagues compared the susceptibility of transgenic mice 
carrying human IL37 with control mice to colitis induced by dextran sodium sulfate (DSS) in 
drinking water 38. DSS-mediated colonic inflammation is significantly reduced in the 
transgenic mice, and such amelioration is associated with a reduced leukocyte infiltration and 
dampened expression of IL-1β, and TNF-α. Nold et al. observed a significant attenuation of 
the effects induced by non- lethal endotoxic shock through LPS intraperitoneal injection in 
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IL37 transgenic mice 36. In addition to weaker hypothermia, transgenic mice achieved 
respiratory compensation of the metabolic acidosis, protection against a rise in blood 
potassium concentration, and prevention of liver damage in the LPS induced endotoxic 
model. Those physiological findings in IL37 transgenic mice were paralleling a reduction in 
various cytokines, such as IL-6, IL-1β, IFN-γ in different compartments as compared with 
control wild-type mice. Those protected effects observed in IL37 transgenic mice showed 
dosage response because homozygotes always demonstrated more pronounced protection 
from LPS induced endotoxic shock and less pro-inflammatory cytokine production than 
heterozygotes 36.  
The anti- inflammatory activity of IL37 can be further demonstrated in vitro cell 
culture experiment. THP-1 cells, a human monocytic cell line, transfected with IL37 
exhibited reduced expression of several inflammatory molecules such as IL-1β, TNF and IL-
8 upon challenge by LPS 36. Similar pattern of reduction in those pro-inflammatory cytokines 
upon IL-1β challenge was also observed in epithelial cell line A549 transfected with IL37 36. 
Further mechanistic studies have shown that the anti- inflammatory activity of IL-37 is 
mediated by enhancing TGF-β signals through a direct association with Smad3, a 
transcriptional factor that constitutes the major effector of signaling downstream of TGF-β 4, 
36.  From both in vivo and in vitro experimental models, it has been clearly indicated that IL-
37 is a natural suppressor of innate inflammatory and immune responses that reduces the 
extent and severity of inflammatory insult.  
Other than colitis, hepatitis, dermatitis and rheumatoid arthritis, the activity of IL-37 
hasn’t been explored in other diseases 39, 38.  The knowledge gap of how IL-37 is involved in 
periodontal disease pathogenesis remains to be filled. Our GWAS Caucasian study has 
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provided some clues of the involvement of IL-37 in the inflammatory pathogenesis of 
periodontal disease. The first trait locus contains two non-synonymous, coding single 
nucleotide polymorphisms (SNPs) within exon 2 [rs3811046 T/G and rs3811047 G/A] that 
result in a predicted altered IL-37 protein structure [(A34V) and (A42T)], respectively. These 
two SNPs demonstrate linkage disequilibrium because they are almost always present in the 
same minor allele. This variant 1 [IL37v1] is relatively common with a minor allelic 
frequency of 30% and is found to be significantly associated with high levels of IL-1β within 
the GCF [OR=1.70, (1.53-1.89), p=6.8 X10-21]. This p value is statistically significant, as it 
readily exceeds the strict genome-wide significance threshold value of p<5X10-8, which is 
required by Bonferroni correction for multiple comparisons. This IL37 variant is also 
associated with more severe periodontal disease [e.g. greater inflammation with higher 
gingival index scores (GI, p=0.016), greater extent probing depth>4mm (PD4+mm, p=0.026) 
and greater bone loss as reflected in attachment loss >4mm (AL4+mm, p=0.04)]. A second, 
less common locus within IL37 (8.5% frequency of minor allele) has 5 non-synonymous, 
coding SNPs [rs2708943(exon 4), rs2723183(exon 4) , rs2723187(exon 5) , rs2708947(exon 
6) and rs2723192 (exon 6), OR=1.52 (1.31-1.84), p<4.2X10-7]. The association between this 
trait locus with IL-1β within the GCF is approaching to the significance threshold.  The 
predicted protein sequence for this variant [IL37V2] is estimated to have a high probability of 
inducing structural alterations in IL-37 (p=0.04).  The data from this unpublished study 
suggest a similar anti- inflammatory role of IL37 in periodontal disease because the predicted 
alteration of protein structure due to the missense mutations present in both trait loci may 
disrupt the normal activities of this cytokine in periodontium. The altered protein structure of 
IL37 may possibly intervene with the homeostasis between host and microflora present in the 
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biofilm in such a way that skews the inflammatory responses to favor the destruction of 
attachment and bone resportion. 
According to literature and data from our GWAS study, we hypothesize that genetic 
IL37 variants cause a functional defect in IL-37 that is associated with an excessive pro-
inflammatory innate immune response in chronic periodontitis. Epidemiological studies 
have shown that approximately 90% of the US population exhibits gingivitis, with 48% of 
the US adult population having periodontitis40, 41. More importantly, evidence suggests that 
periodontal disease carries potential risks for worsening various systemic conditions 
including atherosclerosis, stroke, diabetes, and etc42, 43, 44. Genetics plays a role in the 
progression of periodontal disease. Studies by Michalowicz in monozygotic and dizygotic 
twins  provided the first estimates of heritability and suggested that about half (48%) of the 
variance in disease could be attributable to genetics 45. Identification of important genetic risk 
variants that contribute to periodontal disease is the approach to study diseases with complex 
trait, such as periodontal disease. Several genetic polymorphisms of several pro-
inflammatory molecules, such as IL1, FcγRs, TNFA, have been associated with periodontitis 
46, 47. However, no association linking IL37 and periodontal disease has been reported so far. 
Based on our GWAS study, IL37 genetic variation may confer the increased susceptibility to 
chronic periodontitis due to functional alteration of this molecule. 
One of the scientific merits of this study is to understand how a genetic basis of an 
anti- inflammatory gene, IL37, is involved in the presentation of chronic periodontitis.  
Unraveling the genetic basis of pathogenesis will lead to improved diagnosis and prognoses 
to identify individuals at risk for disease to optimize prevention strategies. In addition, 
exploration of molecular mechanism of how IL37 is involved in periodontal inflammation 
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helps to develop effective and novel therapies to target this anti- inflammatory molecule to 
restore periodontal health. 
Statements of purpose, hypothesis and specific Aims: 
 The role of IL-37 hasn’t been explored in periodontal disease. Our GWAS study 
suggested an anti- inflammatory activity of IL37 in the pathogenesis of periodontal disease. 
We are seeking to understand the expression pattern of IL37 in gingival biopsies and 
compare the transcriptional level of IL37 in biological samples from chronic periodontitis 
patients with control subjects of periodontal health. We are also aiming to study the 
association of SNPs in the first IL37 trait locus identified from our GWAS data with the 
transcriptional expression of inflammatory genes including IL37, IL1B and IL6.   Further, we 
will use in vitro cell culture models representing different cell populations present in human 
gingiva to study the expression profile of IL37 upon stimulation by E. coli LPS. Two specific 
aims are developed to test our hypothesis that genetic IL37 variants are associated with an 
altered pro-inflammatory innate immune response in chronic periodontitis. 
Aim 1: to compare the transcriptional expression levels of IL37, IL1B and IL6 in 
biopsies collected from chronic periodontitis patients (case) and subjects with 
periodontal health (control); and characterize the IL37 genotypes (rs3811046 T/G and 
rs3811047 G/A in the first trait locus) and correlate different IL37 genotypes with the 
transcriptional profiles of those genes; 
In this aim, we will first to identify the expression pattern of IL-37 in biopsied 
gingival tissues by immuno- fluorescence technique in frozen sections and then compare the 
transcriptional level of IL37 in gingival biopsies collected from periodontitis patients with 
controls by real- time PCR. We will also genotype IL37 based on the first identified locus 
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carrying two SNPs (rs3811046 T/G and rs3811047 G/A) by extracting DNA from biopsies 
and pyro-sequencing technique. We will also associate the presence of minor allele and 
different genotypes of IL37 with periodontal disease status and transcriptional profiles of 
those inflammatory genes including IL1B and IL6, in addition to IL37. 
Aim2: to investigate the kinetic of IL37 transcriptional expression in gingival 
fibroblasts, THP.1 Cells and oral keratinized cells  in the response to E. Coli LPS 
challenge   
We will analyze the transcription of IL37, IL1B and IL6 by real-time PCR in vitro in 
three different cell cultures that represent the major cell populations present in human 
gingiva in response to the challenge by E.Coli PLS. This information will help to map the 
cellular sources for IL37 expression in periodontium.  
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CHAPTER 2: EXPRESSION OF INTERLUKIN-37 (IL37) AND THE GENETIC 
VARIATIONS OF IL37 IN RELATION TO CHRONIC PERIODONTITIS 
Introduction 
 
Periodontitis is caused by the abnormal inflammatory and immune responses initiated 
by the bacteria 1, 2. Activation of the innate immune system in periodontal disease results in 
the synthesis and secretion of various chemokines and cytokines, such as interleukin-1β, (IL-
1β), IL-6, IL-8, tumor necrosis factor-α (TNF-α), etc., most of which propagate inflammation 
and may potentially cause destruction in periodontium. However, the periodontal destruction 
caused by inflammation is usually episodic and slow-progressing in chronic periodontitis 
patients. The homeostasis of inflammation, though altered in periodontal disease, must be 
maintained by anti- inflammatory mechanisms in the long intervals between breakdowns of 
periodontal supporting apparatus. So far several molecules have been described to possess 
anti- inflammatory activities, such as resolvins, IL-10 and transforming growth factor β 
(TGF-β) 3, 4, 5. Pathways to down regulate the extent and severity of inflammation in hosts 
may provide insight for the novel therapeutic potential to reduce the destruction caused by 
periodontal disease.  
Periodontal disease, similar to most other complex inflammatory diseases, is a 
polygenic disorder involving gene to gene interaction and exhibits complex genetic traits. 
The susceptibility to periodontal disease has been explored by association studies aiming for 
targeting genetic markers and candidate disease-modifying genes by identification of single 
nucleotide polymorphisms (SNPs). Many previous studies have discovered important SNPs 
Fig.1 
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in genes encoding molecules of the host defense system in chronic periodontitis 6, 7. Kornman 
et al first described a composite IL1 polymorphism including -889bp (C to T transition) in 
IL1A and +3953bp (C to T transition) in IL1B that was significantly related to the severity of 
periodontitis in non-smoking Caucasians 8. Additionally, monocytes from individuals with 
homozygous IL1B +3953T allele were shown to produce 4-fold more IL-1β, and monocytes 
with heterozygous IL1B +3935T allele exhibited two-fold more IL-1β than cells without this 
SNP at the +3953 locus 8, 9. It has been concluded that IL1 genotypes might be considered as 
a risk factor for the severity of periodontitis in certain racial groups, especially non-smoking 
Caucasians population (Lindhe J clinical Periodontology 4th edition). Other association 
studies have identified certain SNPs of other genes involved in immune response including 
IL10, TNFA, Fc receptor for immunoglobulin G (FcRs), etc 10, 11, 12.  All those studies have 
suggested that the association of certain SNPs with periodontitis is usually race specific and 
cannot be generalized across all racial groups. 
From a genome-wide association study (GWAS) including 4910 Caucasians with 
known levels of gingival crevicular fluid (GCF) IL-1β, we have identified two novel 
quantitative trait loci with missense mutations within the coding region of IL37 that are both 
inversely and significantly associated with GCF-IL-1β levels. IL37, which was previously 
designated as IL-1 family member 7 (IL1F7) 13, is mapped to the cluster of genes on human 
chromosome 2, which contains other IL-1 family members except IL18 and IL33. 
Sequencing analyses have shown that IL1F7 gene structure contains 6 exons and five 
splicing variants present (IL1F7a-e) with IL1F7b to be the best characterized. Upon 
induction with bacterial endotoxins such as lipopolysaccharine (LPS), peripheral blood 
mononuclear cells (PBMCs), dendritic cells and colon epithelial cells can express IL-3714, 15. 
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Although it is structurally similar to other IL-1 family members, IL-37 has been reported to 
possess a unique anti- inflammatory activity 14. McNamee and colleagues 16 discovered that 
the dextran sodium sulfate (DSS)-mediated colonic inflammation is significantly reduced in 
the IL37 transgenic mice, and such amelioration is associated with a reduced leukoc yte 
infiltration and dampened expression of IL-1β, and TNF-α. Nold et al. observed a significant 
attenuation of the effects induced by non- lethal endotoxic shock through LPS intraperitoneal 
injection in IL37 transgenic mice 14. Those physiological findings in IL37 transgenic mice 
paralleled a reduction of a panel of pro- inflammatory cytokines, such as IL-6, IL-1β, IFN-γ 
in different compartments as compared with control wild-type mice. 14.  
The anti- inflammatory activity of IL37 was further demonstrated in vitro cell cultures. 
THP-1 cells transfected with IL37 exhibited reduced expression of several inflammatory 
molecules such as IL-1β, TNF-α and IL-8 upon challenge by LPS 14. Similar pattern of 
reduction in those pro- inflammatory cytokines upon IL-1β challenge was also observed in 
epithelial cell line A549 transfected with IL37 14.  
The activity of IL-37 hasn’t been explored in diseases other than colitis, hepatitis, 
dermatitis and rheumatoid arthritis 17, 16 yet.  The knowledge gap of how IL-37 is involved in 
periodontal disease pathogenesis remains to be filled. Our GWAS Caucasian study has 
provided some clues of the involvement of IL-37 in the pathogenesis of periodontal disease. 
The identified novel trait locus contains two non-synonymous, coding single nucleotide 
polymorphisms (SNPs) within exon 2 [rs3811046 T/G and rs3811047 G/A] that result in a 
predicted alteration of IL-37 protein structure [(A34V) and (A42T)], respectively. These two 
SNPs demonstrate linkage disequilibrium because they are almost always present in the same 
allele. This variant  is relatively common with a minor allelic frequency of 30% and is found 
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to be significantly associated with high levels of IL-1β within the GCF [OR=1.70, (1.53-
1.89), p=6.8 X10-21].  
In this study, we are seeking to understand the expression pattern of IL37 in gingival 
biopsies and compare the transcriptional level of IL37 in biological samples collected from 
chronic periodontitis patients with control subjects with periodontal health. We are also 
aiming to study the association of both SNPs in this identified IL37 trait locus (rs3811046 
and rs3811047) with the transcriptional expression of inflammatory genes including IL37, 
IL1B and IL6.   Further, we will use in vitro cell culture models representing different cell 
populations present in human gingiva to study the expression profile of IL37 upon 
stimulation by E. coli LPS. By employing both in vivo and in vitro approaches, we will test 
our hypothesis that genetic IL37 variants are associated with an altered pro- inflammatory 
innate immune response in chronic periodontitis. 
Materials and Methods 
Participants and tissue collection 
 
This study was approved by the Biomedical Institutional Review Board of the 
University of North Carolina at Chapel Hill (UNC). Written informed consent was obtained 
from all study participants. All subjects are aged between 18-70 years of different races 
including Caucasians, African Americans, Hispanics, Asians and others. 
  In this cross-sectional clinical study, a total of 61 subjects were enrolled. 24 of the 
subjects were patients diagnosed with chronic periodontitis, exhibiting probing depth 
(PD) >4mm and clinical attachment loss >3mm. Another 37 subjects served as control 
subjects with periodontal health, which is defined by no site of PD greater than 3mm or 
attachment loss greater than 2mm. Periodontitis patients were recruited from the Department 
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of Periodontics, University of North Carolina at Chapel Hill, School of Dentistry, while 
control subjects were enrolled either from the General and Oral Health Clinical Center at the 
School of Dentistry who volunteered for this study after screening or from the Department of 
Periodontics and presented for clinical crown lengthening procedure. Major exclusion criteria 
are: 1) use of either antibiotics or non-steroidal anti- inflammatory drugs (NSAIDs) within 1 
month before enrollment; 2) medical treatment for systemic diseases 3 months prior to the 
gingival biopsy or periodontal surgery; 3) active infectious diseases, pregnancy, cancer or 
systemic diseases with oral manifestations; 4) severe unrestored caries or aggressive 
periodontitis. Periodontal clinical measurements, including probing depth (PD), clinical 
attachment loss (CAL), bleeding on probing (BOP), and plaque index (PI) will be obtained 
prior to the biopsies. Biopsies obtained from periodontitis patients were collected from the 
most severe site during the scheduled periodontal surgeries.  
 Upon removal, all biopsied gingival tissues were divided at least into two pieces. One 
piece, used for genotyping analysis, was kept in the −80°C freezer immediately, while the 
other half, used for real-time polymerase chain reaction (RT-PCR), was incubated with 
RNA-later (Applied Biosystems/Ambion, Austin, TX, USA) overnight at 4°C, and then 
transferred to −80°C freezer for storage.  In addition, another piece of tissue from 5 chronic 
periodontitis biopsies and 5 control biopsies were immersed in Tissue-Tek® O.C.T™ 
compound (Sakura Finetek, Netherland) and snap frozen by dry ice and then stored in −80°C 
freezer for histological study.  
DNA isolation and genotyping of IL37 
Genomic DNA was extracted from the collected gingival biopsies using a DNeasy 
Mini kit (QIAgen, Valencia, CA, USA) according to the manufacturer’s manual. The primers 
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and sequencers designed by Assay Design Software 2.0 (QIAgen) for SNP detection were 
listed in table 1. For each PCR amplicon generated by forward and reserve primers was 
directly genotyped in a real-time DNA synthesis approach by prosequencing technology. In 
brief, 6-8 ul of PCR product was mixed with 2ul of streptavidin-coated sepharose beads and 
40ul of PyroMark binding buffer (QIAgen). After captured by the PyroMark vacuum prep 
filter tips (QIAgen), the beads to which biotin- labeled single strand PCR product attached 
were washed sequentially with 70% ethanol, denaturing buffer, and PyroMark washing 
buffer, and then released into a PyroMark Q96 HS plate (QIAgen) onto which 12ul of 
PyroMark annealing buffer mixed with 3.6pmol of sequencer corresponding to each 
amplicon has already been preloaded. After heated for 2 minutes at 86°C, the plate was then 
loaded onto a PSQ HS 96 Pyrosequencing system (QIAgen). The sequencing was determined 
by Pro Gold CDT reagents (QIAgen). The presence of variation or the copy of the minor 
allele (heterozygote or homozygote) was determined by the pyrogram pattern based on the 
peak height.  
Table 1. Primers and sequencers used for IL37 genotyping 
SNP sites Sequences AnNealing Temperature (°C) 
Rs3811046 and 
Rs3811047 
             
  
Rs2708943 and 
Rs2723183 
 
 
Forward: 5’-TGCTAACCTCACTGCGTCTGAC-3’ 
Reverse: 5’-ATCACCTCACCCCGAGGC-3’ 
Sequencer: 5’-CCTTACTTGTGTGAACAAA-3’ 
 
Forward: 5’-AAAGGGCTGAGTCTTCCATTT-3’ 
Reverse: 5’- TTGTGATCCTGGTCATGAATG-3’ 
Sequencer:5’- TCTGGTGATATTGATCTAGG-3’ 
 
65 
 
 
63 
 
Cell cultures 
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A human monocytic cell line (THP.1), which was originally purchased from 
American Type Culture Collection (ATCC, Manassas, VA) , was maintained in RPMI 1640 
culture medium (Invitrogen, Grand Island, NY) supplemented with 10% fetal bovine serum 
(FBS) (Mediatech, Manassas, VA), 5X10-5 M 2-mercaptoethanol (Sigma-Aldrich, St. Louise, 
MO), and 1% penicillin/streptomycin (Invitrogen). Cells with a density of 1X106 were 
seeded into a 6-well plate just before use.  
A primary human gingival fibroblast cell culture (HGF), which was originally 
purchased from ATCC, was maintained in DMEM culture medium supplemented with 10% 
fetal bovine serum (FBS, Mediatech) and 1% penicillin/streptomycin (Invitrogen). 0.4X105 
cells were seeded into a 6-well plate 48 hours prior to challenge. 
A primary human gingival epithelial progenitor cell culture (HGEPp, CELLnTEC 
Advanced Cell Systems, Bern, Swizerland) was maintained in CnT basal medium (CnT-
BM.1) supplemented with CnT-24.S (CELLnTEC Advanced Cell Systems). 0.5X106 cells 
were seeded into a 24-well plate 24 hours prior to challenge.   
 E.coli Lipopolysaccharide (LPS) (Sigma-Aldrich) was diluted with each individual 
cell culture medium and added to each cell culture to achieve either 100ng/μl or 1μg/μl 
according to experimental protocols. After challenging for different intervals, cells were 
collected and RNA was isolated.  
RNA isolation and quantitative Real-time RT-PCR 
Total RNA was isolated from gingival biopsy samples and cells with a RNeasy Mini 
Kit (QIAgen, Valencia, CA). cDNA from 300-600ng isolated RNA was synthesized with a 
SuperScript VILO cDNA synthesis kit (Invitrogen). Quantitative Real-time RT-PCR of the 
messenger levels of IL1B, IL6 and IL37 were determined by an X20 assay on-demand gene-
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expression assay mix (Hs01555410_m1, Hs00985639_m1, and Hs00367201_m1, 
respectively, Applied Biosystems/Ambion, Austin, TX) in a 7000 Sequence Detection 
System (Applied Biosystems/Ambion). A TaqMan® GAPDH control reagents kit was used 
as an internal control (Applied Biosystems/Ambion). 
Immunofluorescence  
The O.C.T embedded and frozen preserved biopsy samples were stored at -80°C 
freezer until use. After cryostat sectioning, the frozen gingival biopsies from periodontal 
health and chronic periodontitis were fixed with 70% ethanol for 30 seconds and then 
immersed in acetone for another 15 minutes. After fixation, the tissue slides were blocked for 
1 hour at room temperature, and then incubated overnight a t 4°C with monoclonal antibody 
specific for IL-37 (6.7μg/ml, Cat #1975-IL, R&D Systems, Minneapolis, MN) or vehicle. 
The blocking PBS buffer contains 8% bovine serum albumin, and 0.1% Triton-X-100, and 
the antibody was diluted with the same blocking buffer. After vigorous washing with 1X 
PBS containing 0.1% Triton-X-100 for, the slides were incubated for another hour at room 
temperature with a donkey anti-goat IgG secondary antibody labelled with northenlights 557 
Fluorochrome (NL007, R & D Systems). Sections were then washed with PBS, mounted 
with ProLong Gold antifade reagent with DAPI (Invitrogen) and coverslipped. 
Immunofluorescence signals were observed using confocal microscopy (Carl Zeiss LSM 710 
Confocal Microscope, Thornwood, NY). 
Statistics: 
Pearson’s chi-square or exact Pearson chi square test was applied to test the null 
hypothesis that the distribution of genotypes at both rs3811046 and rs3811047 loci was not 
different among different racial groups. The genotypes are categorized by homozygous 
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populational major alleles and heterozygous alleles/homozygous for populational minor 
alleles. The same statistical analysis was also performed to test the gender difference between 
periodontitis patient group and control group of subjects with periodontal health.  
Two sample student-t test was used to detect the difference of periodontal indices and 
age between diseased and control groups. To compare the transcriptional expression of 
cytokines between diseased and control subjects, we applied non-parametric Wilcoxon-
Mann-Whitney rank test. Using the same statistical analysis, we compared the transcription 
of those cytokines between genotypes at both loci in Caucasian subjects and African-
American subjects. The level of significance was set at p=0.05. 
Results 
Demographic information of the clinical subjects: 
 The demographic information, periodontal indices and racial status of the study 
participants are listed in Table 2.  The mean age of patients with chronic periodontitis was 
significantly older than subjects with periodontal health (Table 2, p=0.014). The proportion 
of males in the chronic periodontitis group was significantly higher than the control group 
(56% vs. 30%, respectively, p=0.04, Table 2). The distribution of different racial groups was 
not significantly different between the two groups of participants. As expected, sites with 
chronic periodontitis exhibited significantly higher measurements for both probing depth and 
attachment loss when compared to the periodontally healthy sites (p<0.0001 for bo th, Table 
2).  
Genotypes of IL37 in the clinical subjects: 
 21 out of 37 (56.8%) Caucasian subjects and all the participants from Hispanic, Asian 
and other races (100%) presented homozygous “T” allele at the rs3811046 locus with the TT 
 27 
 
genotype (or 1.1), which is in contrast to only 2 out of 17 (11.8%) African Americans who 
were homozygous for “T” allele at this locus. The prevalence for 1.1 genotype at this locus 
was significantly higher in non-African American subjects than African American 
participants (p=0.0005, Table 3).  However, the prevalence of 1.1 genotype and other 
genotypes TG/GG (or 1.2/2.2) in periodontitis group was not significantly different from that 
of periodontal health group (p=0.3, data not shown). 
 Similarly, 27 out of 44 (61.4%) non-African American subjects presented 
homozygous “G” genotype (GG or 1.1) at the rs3811047 locus, while only 3 out of 17 
(17.6%) African Americans were homozygous for “G” allele.  The distribution of 1.1 
genotype was significantly different among different racial groups with higher percentage of 
GA/AA genotype (or 1.2/2.2) at this locus in African American subjects than in non-African 
American group (Table 3, p=0.001). When disease status was considered, again the 
prevalence of 1.1 genotype in periodontitis patients was not statistically different from the 
subjects with periodontal health (p=0.4, data not shown).  
Changes of transcriptional levels of cytokines IL37, IL1B and IL6 in gingival biopsies 
with periodontitis 
 The transcriptional level of IL37 was not significantly different from gingival 
biopsies between periodontitis and periodontal health group (p=0.97, Figure 1A). The 
transcriptional level of IL1B from the gingival biopsies with periodontitis was higher than 
that in the periodontal healthy group, though the difference was also not statistically 
significant (p=0.11, Figure 1B). However, the messenger level of IL6 was significantly 
elevated in samples collected from chronic periodontitis patients in comparison to biopsies 
with periodontal health (p=0.027, Figure 1C). 
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Transcriptional levels of cytokines IL37, IL1B and IL6 in gingival biopsies in relation to 
genotypes of IL37 at rs3811046 and rs3811047 loci 
 Because the presence of genetic variations in the loci of IL37 may affect its 
transcriptional activity, messenger stability, and the transcription activity of other 
proinflammatory cytokine genes, we observed the messenger levels of IL1B and IL6, in 
addition to IL37, in relation to the genotypes of IL37 at both rs3811046 and rs3811047 loci. 
The transcriptional levels of IL37, IL1B and IL6 were not significantly different between the 
homozygous major T allele (TT or 1.1) and TG/GG genotypes (1.2/2.2) at rs3811046 locus 
(p=0.15, 0.97, and 0.23, respectively, Figure 2A, 2B and 2C).  
Because the G (2) minor allele was more prevalent only in African American subjects, 
which is different from other racial groups, we next compared the transcriptional levels of 
those cytokine genes between different genotypes stratified by race. Since there were very 
few non-Caucasian and non-African American subjects, we only focused on Caucasian and 
African American participants. In Caucasian subjects, the transcriptional level of IL37 in 
gingival samples positive for TT (1.1) genotype was not significantly different from samples 
with TG/GG (1.2/2.2) genotypes at the rs3811046 locus (p=0.12, Figure 3A). Nor was the 
transcriptional level of IL1B from samples with 1.1 genotype significantly different from 
biopsies with 1.2/2.2 genotypes (p=0.11, Figure 3B). However, a trend of higher level of 
IL37 and IL1B was present in the 1.1 genotype.  The messenger level of IL6 in samples 
present GG (1.1) genotype was significantly higher than TG/TT (1.2/2.2) samples in 
Caucasian participants (p=0.02, Figure 3C).   
In African American participants who exhibited a G (or 2) dominating allele, we 
compared the transcriptional levels of those cytokine genes in samples with homozygous G 
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allele genotype (GG or 2.2) with samples present for other allelic variations (GT/TT or 
2.1/1.1). We found that the transcriptional expression of both IL37 and IL1B from samples 
with 2.2 genotypes was not significantly different from samples present 1.1/1.2 genotypes 
(p=0.09 and p=0.45, respectively, figure 4A and 4B). However, the transcriptional level of 
IL6 in samples with 2.2 was significantly higher than other genotypes in African American 
subjects (p=0.014, Figure 4C).  
 Due to the similar consideration that in African Americans the A allele is more 
dominating than G allele, while the G allele is more prevalent in non-African American 
population, we separated the Caucasian participants from the African-Americans for 
comparisons. Because rs3811047 presented strong linkage disequilibrium with rs3811046, 
the results for rs3811047 mirrors what we obtained from rs3811046. Briefly, the 
transcriptional levels of IL37, IL1B and IL6 were not significantly different between the GG 
genotype (GG or 1.1) and GA/AA (1.2/2.2) genotypes at rs3811047 locus in overall 
participants (p=0.11, 0.71, and 0.38, respectively, data not shown). The expression of IL37 
and IL1B among Caucasians were not significantly different between 1.1 genotype and 
1.2/2.2 genotypes (p=0.1 and p=0.14, respectively, data not shown), while the expression of 
IL6 was significantly higher in samples with genotype GG (1.1) than from samples with 
GA/AA (1.2/2.2) genotypes (p=0.03, Figure 5A). 
 In African American subjects, the transcriptional levels of IL37 and IL1B in samples 
present AA (2.2) genotypes were not significantly different from samples with AG/GG 
(1.2/1.1) (p=0.2 and p=0.9, respectively, data not shown). Again, the messenger level of IL6 
was significantly elevated in samples with 2.2 genotype at this locus than 1.2/1.1 variations 
(p=0.04, Figure 5B).  
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Immunofluorescence staining of IL-37 in frozen sections of gingival biopsy samples: 
 IL-37 staining was prevalently present across the epithelial layer of the gingival 
biopsy samples (Figure 6A-C).  The staining was primarily intracellular. Scattered staining of 
IL-37 can be also identified in the sub-epithelial layer to a milder extent. The staining pattern 
of IL-37 in frozen sections collected from the periodontitis site (Figure 6A and 6B) was not 
distinctly different from the sample collected from a control subject (Figure 6C), though the 
staining seemed stronger in the diseased sample.  
Transcriptional levels of IL1B, IL6 and IL37 in gingival fibroblasts challenged with 
E.coli LPS: 
 Upon challenge by E.coli LPS (1µg/ml) for 24 hours, the messenger level of IL1B in 
oral gingival fibroblasts was elevated about 287-fold as compared to the control cells 
challenged with cell culture medium (Figure 7A). Similarly, the transcriptional level of IL6 
was induced about 40-fold in LPS challenged cells in comparison to mock challenged cells at 
24 hours (Figure 7A). However, the transcriptional level of IL37 in fibroblasts was 
unchanged in response to LPS stimulation (F igure 7B). This may suggest that gingival 
fibroblast present in periodontium is not the major source for IL37 production. 
 THP.1 cells, which are a monocytic cell line, exhibited elevated IL1B and IL6 
transcriptional expression by about 240-fold and 274-fold, respectively, in response to LPS 
challenge in comparison to mock challenge at 24 hours (figure 8A).  Treatment with LPS 
increased IL37 in a time-dependent manner as compared to control cells.  After 4 hours of 
treatment messenger level of IL37 was induced about 1.7-fold, while the transcription was 
induced about 2.3-fold at 24 hours in comparison to mock treated cells (figure 8B). However, 
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the magnitude of IL37 transcriptional induction in THP.1 cells is not as dramatic as other two 
cytokines.  
 The gingival epithelial cells were challenged with a lower dose of E.coli LPS at the 
100ng/ml and a higher dose at 1µg/ml at 6 hours, 24 hours and 48 hours. The increase of 
IL1B and IL6 transcriptional levels in gingival epithelial cells demonstrated both dose- and 
time-dependent manner (figure 9A, 9B): the higher concentration of LPS in the cell culture 
resulted in more elevation of transcription for both molecules than the lower concentration, 
and the messenger levels of both cytokines increased as cells were treated longer by LPS. 
The IL37 transcriptional expression pattern mimicked the kinetics of IL1B and IL6 
production by LPS treatment (Figure 9C). It was noticeable that the fold change of IL37 upon 
challenge by LPS in gingival epithelial cells was higher than that in THP.1 cells.  
Discussion 
 In this study, we used human gingival biopsy samples collected from periodontitis 
patients and subjects with periodontal health to analyze the genetic variations at rs3811046 
and rs3811047 loci of IL37 and related the genotypes at both loci to disease status and race. 
We also compared the transcriptional levels of several cytokine genes including IL37, IL1B 
and IL6 from samples with periodontitis to control biopsies and genotypical variations of 
IL37 stratified by race. We further observed the expression pattern of IL-37 in gingiva by 
immunofluorescence approach. At last, using different cell cultures that represent different 
cell populations in periodontium, we explored the readiness of IL37 transcriptional activation 
in different cell types upon challenge by E.coli LPS. 
 IL37 was first identified by several independent groups in 2000 18, 19, 20. It has been 
designated as IL1F7 previously. Many human tissues have been discovered to express IL-37 
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such as colon, tonsils, placental tissue, normal breast, testis, thymus, etc 19, 21. Peripheral 
blood monocytic cells and dendritic cells are also the source of IL-37.In this study, we 
reported that gingival tissue is also the source for IL37 expression. Immunofluorescnce 
staining clearly demonstrated that the epithelium layer of gingival biopsies taken from both 
diseased and control patients moderately expressed IL37. IL-37 staining seems to be in the 
cytoplasm of epithelial cells across the whole layer of epithelium. The production of IL-37 in 
the gingival epithelium has been verified by a gingival epithelial progenitor cell line unpon 
challenged by E. Coli LPS at the transcriptional level. This epithelial cell line exhibited a 
both time-dependent and LPS dose-dependent elevation of the IL37 messenger level, which 
coincided with the transcriptional patterns of IL1B and IL6. The messenger level of IL37 was 
saturated at 48 hours because increasing LPS concentration to 1μg/ml in the cell cuture 
medium didn’t further elevate its transcription as compared to lower dose (100mg/ml) 
challenge. It seems that barrier epithelium separating commensal microbiota and pathogenic 
bacterial microorganisms from the inner tissue poccesses IL-37 production activitiy, since 
colon epithelium was also found to produce IL-37 in humans 14. Therefore, it is possible that 
lining epithelium interfaced with commensal or invading microorganisms may synthesize 
and secret IL-37 to keep the homeostatic state of the mucosal defense to prevent tissue 
destruction induced by uncontrolled production of inflammotry molecules as repsonded to 
the constant microbial challenge from the bio-film. It is reasonable to argue that epithelial 
cells express IL-37, which possesses the anti- inflammatory activity, as a protective 
mechanism to tune down the inflammation mounted by various pro-inflammatory cytokines, 
enzymes or chemokines. However, the signaling pathway(s) that regulate IL37 transcription 
in gingival epithelial cells remain to be elucidated. Recently, it has been reported that PI3K, 
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MAP kinase and NF-κB pathways are involved in the control of IL37 transcriptional 
activation in intestinal epithelial cells challenged by TNF-α 15. 
 We also observed scattered staining of IL-37 in the sub-epithelial layer in the gingival 
biopsies. From the results of in vitro cell culture experiment, it is apparent that monocytic 
cells, but not gingival fibroblasts, respond to LPS stimulation by increasing IL37 
transcriptional activity. So far it hasn’t been reported that fibrob lasts from any source express 
IL-37. Although gingival fibroblasts share some innate immunological response with 
monocytic cells by producing inflammatory cytokines as reported in this study 22, 23, there is a 
divergent regulatory mechanism for IL-37 production between those two types of cells.  
Although from the immunofluorescence staining it is difficult to differentiate the cell types 
that exhibit positive IL-37 staining in the connective compartment, cells such as macrophage, 
dendritic cells, et al. may constitute the major cell population that produce IL-37 in the 
subepithelial layer of gingival tissue. 
Employing real-time PCR, we observed that the transcriptional expression of IL37 
from biopsies of chronic periodontitis was not significantly different from the samples 
collected from controls with periodontal health. One explanation is that the transcription of 
IL37 is cell type specific, which has been proved in the immunofluorescence and cell culture 
experiments, and the heterogeneity of cell populations in those biopsy samples may mask the 
difference of IL37 production between periodontally diseased and healthy samples. The vast 
amount of fibroblasts present in the gingiva that do not alter transcriptional level of IL37 
upon inflammatory stimulation outweighed the epithelial cells or macrophage/dendritic cells 
that are competent for IL37 production. In addition, we lack of the knowledge of IL37 
transcriptional activation from other cell populations present in gingiva, such as endothelium. 
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Another explanation for the insignificant results is possibly due to the limited sample size in 
this pilot study. The power may be not strong enough to detect the significance.   
In biopsied gingival tissues we observed that the transcriptional level of IL6 in 
samples collected from periodontitis patients was significantly elevated compared to biopsies 
from subjects with periodontal health. However, the IL1B level between those groups was 
not significantly different, though a trend of elevation was present in diseased samples. This 
result is similar to a study performed by Muthukuru et al, who found a non-significant 3-fold 
increase of IL1B transcripts in gingival biopsies from chronic periodontitis patients as 
compared to healthy controls 24. Previous studies have demonstrated that the level of several 
inflammatory molecules, such as IL-6, IL-8, MMPs, etc, was enhanced in the gingival 
crevicular fluid (GCF) samples or tissue biopsied from chronic periodontitis patients as 
compared to controls 25, 26. However, the extent of IL1B elevation in chronic periodontitis 
sites was not significant. Several explanations can be applied. First, the expression of IL-1β 
can be inhibited in the tissue due to the constant challenge by endotoxins of pathogens that 
are omnipresent in the biofilm. This tolerated expression of IL1B has been reported by 
several studies 27, 28.  Second, IL1B expression is subject to the regulation at transcriptional, 
post-transcriptional, and post-translational levels 29, 30. Therefore, the transcripts of IL1B do 
not necessarily correlate to the protein level.  In addition, all the periodontitis patients had 
undergone initial non-surgical periodontal therapy such as scaling and root planning several 
weeks before biopsy collection. The treatment rendered before sample collection may reduce 
the tissue level of IL1B transcripts due to the resolution of inflammation as suggested by 
other studies 31, 32.   
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 We confirmed through pyrosequencing that the major allele at rs3811046 and 
rs3811047 in IL37 locus is “T” and “G” in non-black populations, while populational “G” 
and “A” minor allele are more prevalent in African Americans at both loci, respectively . The 
genotype frequency of cytokine genes varies among different racial groups. For example, the 
GG genotype at the -330 of IL2 didn’t exist among studied African American subjects while 
this genotype was present in 6% White, 14% Asian and 4% Hispanic subjects 33. We further 
demonstrated that the genotypes of IL37 at those two loci were not related to the periodontal 
disease status (p=0.32, data no shown). Nor was the transcriptional expression of IL37 from 
the biopsied samples correlated with its genotypes (data not shown). This may indicate that 
the polymorphisms at those two loci do not seem to predict the susceptibility to periodontal 
disease. This speculation was supported by a recent study reporting that the genotype of 
rs3811047 was not related to rheumatoid arthritis in Chinese Han population 34. The 
frequency of GG genotype is not significantly different from other genotypes (GA/AA) at 
this locus in patients with rheumatoid arthritis as compared to matched non-rheumatoid 
arthritis control subjects 34.  The substitutions at rs3811046 and rs3811047 loci result in a 
predicted altered IL-37 protein structure [(A34V) and (A42T)], respectively. However, those 
non-synonymous SNPs present in the coding region may affect more of its function rather 
than the transcriptional activity. 
In this study we also compared the transcriptional expression of different 
inflammatory cytokines to the genotype of IL37 stratified by race because the dominating 
alleles at both rs3811046 and rs3811047 loci are different in African Americans and 
Caucasians. However, the genotypes at both loci were not related to the transcriptional le vels 
of IL1B either in Caucasian or African American populations, though the presence of at least 
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one copy of minor allele specific to either racial group was related to a trend of decreased 
transcription. It seems that the presence of SNPs at those loci may not necessarily cause the 
change of the transcription efficiency or the stability of IL37 transcripts. This result seems 
contradictory to our GWAS study, which identified that the 1.2 and 2.2 genotypes at both 
loci were associated with a higher IL-1β in GCF from the Caucasian subjects. As mentioned 
above, the discrepancy can be explained by the fact that the transcription of IL1B doesn’t 
necessarily reflect the protein level of IL-1β in the GCF due to its multi- layered complex 
regulation. In addition, the reduction of inflammation in the gingival tissue after initial 
therapy in periodontitis patients in this study may not represent the association between 
genotypes and expression of the molecule as observed in an un-intervened general population.  
Nevertheless, we observed that the presence of minor allele in the genotype (1.2/2.2) 
at both loci in Caucasian participants was related to a significant lower transcriptional level 
of IL6, while in African Americans the presence of a major allele in the genotype (1.2/1.1) 
was associated with a significant reduced messenger level of IL6 in the gingival tissue. 
Previous studies have shown that IL6 transcription can be induced by TGF-β in several cell 
cultures including human bronchial epithelium and airway smooth muscle cells, and this 
induction was very likely mediated through Smad 3 activation 35, 36. It has been known that in 
lung tissue of IL37 transgenic mice the production of IL6 was significantly reduced if Smad3 
was silenced through inhalation of Smad3 specific siRNA 14. Therefore, the anti IL-6 activity 
of IL-37 is mediated through TGF-β signaling pathway specifically involving Smad3. It is 
speculated that the presence of a minor allele at both loci in the exon 2 of IL37 in Caucasians 
may increase the activity of Smad3. It hasn’t been known how IL-37 is wired to TGF-β 
signaling. However, the structural alteration of IL-37 induced by those two miss sense SNPs 
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at both loci seems to enhance Smad3 activity resulting in reduction of IL6 transcription in 
gingival tissue.  
In African American subjects, we found a paradoxical reverse relationship between 
genotypes and the transcriptional level of IL6 in gingival biopsies. It is possible that the 
mechanistic link between genotypes of IL37 at those two loci and the transcriptional 
regulation of IL6 is different from that found in Caucasians. Since genetic variations are 
more diverse in African Americans than other racial groups, the association of certain SPNs 
with disease state and gene expression profile might be modified by the presence of a far 
more complex network of genetic variations. The detailed biological mechanism of how the 
structural changes of IL-37 induced by the allelic variations uniquely affect the transcription 
of IL6 in African Americans remains to be elucidated.  
This study has several limitations. First the sample size is limited due to the nature of 
a pilot study, especially when it is stratified by race. The power to detect the difference of 
genetic variations related to disease among difference racial groups is reduced. We intended 
to increase our participants  to repeat the association analysis between the genotypes and 
transcriptional levels of cytokines. Second, the biopsies we collected from the diseased sites 
do not genuinely reflect the inflammatory nature of the periodontitis due to prior treatment 
rendered before sample collection. In this study we used convenient samples collected from a 
previous study, and all the periodontitis patients recruited in the study had previous non-
surgical therapy. The transcriptional levels of inflammatory molecules are not congruent to 
their protein levels. Therefore, the protein levels of those molecules need to be evaluated by 
collecting GCF samples from untreated participants. In addition, we are also seeking to 
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investigate the regulatory control of IL-6 in monocytic cell lines transfected with IL37 
fragment carrying different genotypes upon inflammatory stimulation.  
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Table 2.  Demographic information and periodontal indices 
Demographic/Clinical   
parameters 
Periodontally Healthy 
(n=37) 
Chronic Periodontitis 
(n=23) 
Age (mean+ SD, years)* 40.3+ 13.2 48.6+ 11.2 
Sex (males/females)# 11/26 13/10 
PD (mean+SD, mm)& 2.25+ 0.8 6.1+ 1.0 
AL (Mean+ SD, mm)& 0.89+ 0.6 5.7 + 1.4 
Alveolar bone loss No Yes 
Caucasians 24 14 
African-Americans 10 6 
Hispanics, Asians and 
Others 
3 3 
* p=0.014 by Student t-test; # p=0.04 by Chi-square (χ2) test; & p<0.0001 by student-t 
test 
 
 
 
Table 3. Genotypes at rs3811046 locus of IL37 in the study participants 
 
  
Race 
  rs3811046 Genotypes 
 
 
Total (%) 
 
TT (%) TG/GG (%) p 
Caucasians 
 
21 (35.0) 
 
16 (26.7) 37 (61.7)  
Hispanics, Asians, 
and Others 
 
6 (10) 
 
0 (0) 6 (10)  
African-
Americans 
2 (3.3) 15 (25.0) 17 (28.3)  
Total 29 (48.3) 31 (51.7) 60 (100) 0.0005* 
* Chi-square (2) test 
 
 
 
 
 
 
 
 40 
 
 
 
 
Table 4. Genotypes at rs3811047 locus of IL37 in the study participants 
 
Race 
  rs3811047 Genotypes 
 
 
Total (%) 
 
GG (%) GA/AA (%) p 
Non African-
Americans 
 
21 (35) 
 
16 (26.7) 37 (61.7)  
Hispanics, Asians, 
and Others 
 
6 (10) 
 
0 (0) 6 (10)  
African-
Americans 
3 (5) 14 (23.3) 17 (28.3)  
Total 30 (50) 30 (50) 60 (100) 0.001* 
* Chi-square (test 
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Figure 1A: 
 
 
 
Figure 1B 
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Figure 1C: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 1. Transcriptional levels of IL37, IL1B and IL6 in gingival biopsy samples 
from sites with periodontitis and with periodontal health. The transcriptional levels of 
IL37 (Figure 1A) and IL1B (Figure 1B) from periodontitis gingival samples were not 
significantly different from control samples with gingival health (p=0.97 and p=0.11, 
respectively), while the messenger level of IL6 was significantly higher in 
periodontitis samples than control samples (p=0.027, Figure 1C). Wilcoxon-Mann-
Whitney rank test was used. 
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Figure 2A: 
 
 
 
 
Figure 2B:  
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Figure 2C: 
 
 
 
  
Figure 3. Transcription of IL37, IL1B, and IL6 in samples with different genotypes 
at the rs3811046 locus of IL37. The transcriptional levels of IL37 (Figure 2A),   
IL1B (Figure 2B), and IL6 (Figure 2C) in samples with TT (1.1) genotype were not 
significantly different from samples with TG/GG (1.2/2.2) genotypes (p=0.15, 
p=0.97, and p=0.23, respectively). Wilcoxon-Mann-Whitney rank test was used. 
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Figure 3A: 
 
 
 
 
Figure 3B: 
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Figure 3C: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 3. Transcription of IL37, IL1B, and IL6 in samples with different genotypes 
at the rs3811046 locus of IL37 from Caucasian participants. The transcriptional 
levels of IL37 (Figure 3A) and IL1B (Figure 3B) in samples with TT (1.1) 
genotype were not significantly different from samples with TG/GG (1.2/2.2) 
genotypes (p=0.12 and p=0.11, respectively), while the messenger level of IL6 in 
samples with TT (1.1) genotype was significantly higher than samples with TG/GG 
genotypes (p=0.02, Figure 3C). The sample size included for each cytokine 
analysis was slightly different in chronic periodontitis group due to the exclusion of 
a failed sample in the real-time PCR experiment, which resulted in a “non 
detected” CT value. Wilcoxon-Mann-Whitney rank test was used. 
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Figure 4A: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 4B: 
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Figure 4C: 
 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 4. Transcription of IL37, IL1B, and IL6 in samples with different genotypes 
at the rs3811046 locus of IL37 from African American participants. The 
transcriptional levels of IL37 (Figure 4A) and IL1B (Figure 4B) in samples with 
GG (2.2) genotype were not significantly different from samples with TG/TT 
(1.2/1.1) genotypes (p=0.09 and p=0.45, respectively), while the messenger level 
of IL6 in samples with GG (2.2) genotype was significantly higher than samples 
with TG/TT (1.2/1.1) genotypes (p=0.0014, Figure 4C). Wilcoxon-Mann-Whitney 
rank test was used. 
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Figure 5A: 
 
 
Figure 5B: 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 5. Transcription of IL6 in samples with different genotypes at the rs3811047 locus of 
IL37 from Caucasian and African American participants. The transcriptional level of IL6 in 
samples with GG (1.1) genotype was significantly higher than samples with GA/AA 
(1.2/2.2) genotypes in Caucasian participants (p=0.03, figure 5A); the messenger level of 
IL6 in samples with AA (2.2) genotype was significantly higher than samples with AG/GG 
(2.1/1.1) genotypes in African American participants (p=0.04, Figure 5B). Wilcoxon-Mann-
Whitney rank test was used. 
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Figure 6A: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6B:  
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Figure 6C: 
 
 
 
 
 
 
 
  
Figure 6. Immunofluorescence staining of IL-37 in gingival biopsies. One sample 
collected from is chronic periodontitis patient is presented with different 
magnifications (Figure 6A and 6B); another sample collected from periodontal health 
is presented in Figure 6C. In both samples, staining of IL-37 was more prevalent in 
the cytoplasm of epithelial cells than the connective tissue in the sub-epithelial 
compartment. 
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Figure 7A: 
 
 
 
Figure 7B: 
 
  
IL1B and IL6 Transcriptional Expression in Gingival 
Fibroblasts upon Challenge by E. Coli LPS at 24 
hours 
IL37 Transcriptional Expression in Gingival 
Fibroblasts 
Figure 7. Transcription of IL1B, IL6 and IL37 in gingival fibroblasts upon challenge with 
E.Coli LPS (1μg/ml) at different time points. The induction of IL1B and IL6 transcription 
was 278 fold and 40 fold, respectively, 24 hours after stimulation of LPS (Figure 7A). The 
transcription of IL37 was unchanged in fibroblasts 24 hours after challenge (Figure 7B). 
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Figure 8A: 
 
 
 
Figure 8B: 
 
 
  
IL1B and IL6 Transcriptional Expression in 
THP.1 Cells upon Challenge by E. Coli LPS at 
24 hours 
IL37 Transcriptional Expression in THP.1 Cells upon 
Challenge by E. Coli LPS 
Figure 8. Transcription of IL1B, IL6 and IL37 in THP.1 cells upon challenge with E.Coli 
LPS (1μg/ml) at different time points. The induction of IL1B and IL6 transcription was 240 
fold and 274 fold, respectively, 24 hours after stimulation of LPS (Figure 8A). The 
transcription of IL37 was induced about 1.7-fold at 4 hours and 2.3-fold at 24 hours after 
challenge with LPS in THP.1 cells (Figure 8B). 
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Figure 9A: 
 
 
 
 
 
Figure 9B: 
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Figure 9C: 
 
 
 
 
 
 
 
 
  
Figure 9. Transcriptional expression of IL6, IL1B and IL37 in an oral epithelial cell line 
(HGEPp) challenged by E. Coli LPS (100mg/μl and 1μg/μl) at different time points.  
Transcription of both IL6 and IL1B exhibited a time- and dose- dependent induction 
upon challenge by LPS (Figure 9A, and 9B). The transcription pattern of IL37 presented 
similar kinetics as IL1B and IL6. 
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